Dr. Gustavo Costa Munguba, M.D., PH.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, 3 South, Atlantis, FL 33462 Phone: 561-548-1711 |
Jay S Wallshein, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5057 South Congress Ave, Ste 403, Atlantis, FL 33461 Phone: 561-433-5200 Fax: 561-433-5206 |
News Archive
Aeterna Zentaris Inc. today announced that the Phase 3 "X-PECT" (Xeloda + Perifosine Evaluation in Colorectal cancer Treatment) clinical trial evaluating perifosine + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
Capitalizing on a cell's ability to roll along a surface, MIT researchers have developed a simple, inexpensive system to sort different kinds of cells - a process that could result in low-cost tools to test for diseases such as cancer, even in remote locations.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
WellAWARE Systems, the developer of breakthrough technology designed to enable proactive and preventive senior care, announced it was recognized with the Technology Innovation: Healthcare Award given by RichTech.
Research by a team of investigators in Finland suggests that the free recall memory deficits common even in early stages Parkinson's disease (PD) are related to structural changes in the brain, specifically parietal cortical gray matter volume.
› Verified 9 days ago